Essential Partners’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.38K Buy
341
+243
+248% +$1.35K ﹤0.01% 1906
2026
Q1
$383 Buy
98
+79
+416% +$351 ﹤0.01% 2507
2025
Q4
$86 Sell
19
-69
-78% -$354 ﹤0.01% 2573
2025
Q3
$539 Sell
88
-13
-13% -$82 ﹤0.01% 2187
2025
Q2
$654 Buy
+101
New +$544 ﹤0.01% 1626

Other funds holding TBI

Essential Partners's TBI Position: Q2 2026 in Review

Essential Partners increased its Trueblue (TBI) stake by 248% in Q2 2026, buying an estimated $1.35K and bringing the position to 341 shares worth $2.38K. The position accounts for ﹤0.01% of the portfolio, ranked #1906.

Essential Partners first reported a position in TBI in Q2 2025 and has held it in 5 quarters since. 114 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • Essential Partners held 341 shares of Trueblue worth $2.38K as of Q2 2026.
  • Essential Partners bought 243 Trueblue shares in Q2 2026, an estimated $1.35K.
  • Trueblue made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1906 holding.
  • Essential Partners first reported a position in Trueblue in Q2 2025 and has held it in 5 quarters since.
  • 114 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.